Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,755,078
-
Share change
-
+21,755,078
-
Total reported value
-
$550,829,286
-
Price per share
-
$25.32
-
Number of holders
-
58
-
Value change
-
+$550,829,286
-
Number of buys
-
58
Institutional Holders of AIMMUNE THERAPEUTICS INC - COM (AIMT) as of Q3 2015
As of 30 Sep 2015,
AIMMUNE THERAPEUTICS INC - COM (AIMT) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,755,078 shares.
The largest 10 holders included
FMR LLC, Foresite Capital Management II, LLC, Aisling Capital LLC, ADAGE CAPITAL PARTNERS GP LLC, Partner Fund Management, L.P., Sectoral Asset Management Inc, RA CAPITAL MANAGEMENT, LLC, RS INVESTMENT MANAGEMENT CO LLC, ALLIANCEBERNSTEIN L.P., and VANGUARD GROUP INC.
This page lists
58
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.